Search the Newsreel

Borr Drilling Ltd (BORR) CFO details extensive option awards and share stake

Borr Drilling Ltd's CFO, Magnus Vaaler, has reported his equity holdings, which consist of employee stock options and direct common share ownership. The options have exercise prices ranging from $1.66 to $6.54 and expiration dates between 2026 and 2029, with vesting tied to continued …

Borr Drilling Ltd (BORR) CAO details 68,729 shares and multiple option grants

Borr Drilling Ltd's Chief Accounting Officer, Jehan Mawjee, reported current equity holdings including 68,729 common shares and multiple employee stock options. The filing indicates no new purchases or sales, but details restricted stock units (RSUs) vesting between 2026 and 2028 and options with exercise …

Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026

Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …

Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate

Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …

Borr Drilling (NYSE: BORR) swings to $241M Q2 loss after major refinancing

Borr Drilling (NYSE: BORR) reported a significant Q2 2026 net loss of $241.4 million, a sharp increase from $29.0 million in Q1 2026, despite revenues of $232.3 million. This loss followed a major refinancing effort where the company issued $2.035 billion in new senior …

Stocks in play: Xanadu Quantum Technologies Limited

Xanadu Quantum Technologies Limited has announced a strategic research partnership with the University of Alberta to develop novel quantum algorithms for cancer treatment. This collaboration aims to accelerate the design of next-generation photosensitizers used in photodynamic therapy. Following this announcement, shares of Xanadu Quantum …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Arbor Realty Trust's Dip Creates Large But Uncovered 12% Dividend Yield (NYSE:ABR)

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

A minimum $20M produce deal is expected to grow Reborn Coffee revenue to ~$28M

Reborn Coffee (REBN) has signed a supply agreement with The Mighty Oak for a minimum of $20 million annually, expected to boost Reborn Coffee's total annual revenue to approximately $28 million, about 3.5 times its 2025 results. This deal converts The Mighty Oak's existing …

JHS Svendgaard Q1 Results: Net profit rises 156% YoY to ₹24 lakh

Silicon Labs (SLAB) Stock Looks Above Fair Value After A 67% Run

Silicon Laboratories (SLAB) stock has seen a 67.3% return over the last year, but current valuations suggest it may be above fair value. Trading at a P/S ratio of 8.8x, higher than the industry average, the stock screens as overvalued. While recent revenue and …

Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB

Wasatch Advisors LP significantly increased its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 125.8% in the second quarter, now owning 115,668 shares valued at $11.5 million. This comes as other institutional investors also adjusted their positions in the medical instruments supplier. Despite an overall …

Xanadu Explores Quantum Design of Light-Activated Cancer Treatments

Xanadu (NASDAQ/TSX: XNDU) and the University of Alberta have partnered to develop quantum algorithms for light-activated cancer treatments, specifically focusing on designing next-generation photosensitizers for photodynamic therapy. This collaboration aims to use quantum computing to model complex light-matter interactions more accurately than classical methods, …

Indo Borax & Chemicals Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

What Dolby Laboratories (DLB)'s Dolby Vision 2 TV Rollout and VVC IP Push Mean For Shareholders

Borr Drilling (NYSE: BORR) Q2 2026 loss widens as refinancing hits earnings but backlog grows

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

BorgWarner Inc. $BWA Shares Sold by Wedge Capital Management L L P NC

Trinity Street Asset Management LLP Sells 11,466 Shares of Clean Harbors, Inc. $CLH

Trinity Street Asset Management LLP has reduced its stake in Clean Harbors, Inc. (NYSE:CLH) by 10.5%, selling 11,466 shares but still retaining 97,925 shares valued at approximately $29.3 million. This comes as institutional investors collectively own 90.43% of the company, and analysts maintain a …

Xanadu Quantum Technologies (TSX:XNDU) Stock Forecast & Analyst Predictions

Xanadu Quantum Technologies (TSX:XNDU) is forecast to see its earnings decline by 22.6% annually, while revenue is expected to grow by 63.2% per year. Despite strong revenue growth and significant partnerships with entities like Oak Ridge National Laboratory and Lockheed Martin, the company is …

Newborn Town Schedules Board Meeting to Approve Interim Results and Consider Dividend

United Laboratories Schedules Board Meeting to Approve 2026 Interim Results

Two Harbors Investments Corp $TWO Shares Purchased by Quantinno Capital Management LP

Core Laboratories Inc. (CLB) stock price, news, quote and history

Renaissance Technologies LLC Buys 11,800 Shares of Nabors Industries Ltd. $NBR

Renaissance Technologies LLC significantly increased its stake in Nabors Industries Ltd. by 236% during the first quarter, acquiring an additional 11,800 shares to bring its total holdings to 16,800 shares valued at approximately $1.45 million. Institutional investors collectively own about 81.92% of Nabors Industries, …

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of "Reduce" from Brokerages

IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

IPCALAB: Net profit surged 80% year-over-year on strong revenue and margin expansion across key segments

Abbott Laboratories Aktie | US0028241000 | ETR:ABL | News & Aktienkurs | FRA:ABL

Brooks Laboratories sets remote e-voting window for September 3 AGM